Literature DB >> 22848235

Involvement of WRN helicase in immortalization and tumorigenesis by the telomeric crisis pathway (Review).

Masanobu Sugimoto1, Yasuhiro Furuichi, Toshinori Ide, Makoto Goto.   

Abstract

The repeated replication of cells shortens telomeres, culminating in their instability, after which most cells cease to replicate and die. However, a small fraction of the cells become immortalized by maintaining telomeres with activated telomerase activity. It has been proposed that WRN helicase encoded by the WRN gene, the causative gene of Werner syndrome (WS), is required for immortalization by the telomeric crisis pathway (TCP) in a system that uses lymphoblastoid cell lines transformed by the Epstein-Barr virus. Taken together, these characteristics indicate that WRN helicase is also required for the immortalization of epithelial cells by TCP and consequent carcinogenesis, suggesting that the tumorigenesis of epithelial cells by TCP is suppressed in WS lacking the WRN helicase function. Notably, in WS the pathway of alternative lengthening of telomeres without activation of telomerase activity has been suggested to be involved in immortalization and tumorigenesis. This factor is consistent with the abundance of non-epithelial cancers in WS in that the ratio of epithelial to non-epithelial cancers is approximately 1:1 in WS patients compared to 10:1 in the general population. A hypothetical scheme showing the role of WRN helicase in immortalization by means of the supposed 'breakage-fusion-bridge cycle' of chromosomes at telomeric crisis is described.

Entities:  

Year:  2011        PMID: 22848235      PMCID: PMC3406460          DOI: 10.3892/ol.2011.298

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  17 in total

Review 1.  Telomere crisis, the driving force in cancer cell evolution.

Authors:  F Ishikawa
Journal:  Biochem Biophys Res Commun       Date:  1997-01-03       Impact factor: 3.575

2.  De novo telomere addition by Tetrahymena telomerase in vitro.

Authors:  H Wang; E H Blackburn
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

3.  Excess of rare cancers in Werner syndrome (adult progeria).

Authors:  M Goto; R W Miller; Y Ishikawa; H Sugano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-04       Impact factor: 4.254

Review 4.  Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene.

Authors:  Jiyue Zhu; Yuanjun Zhao; Shuwen Wang
Journal:  Protein Cell       Date:  2010-02-07       Impact factor: 14.870

5.  Positional cloning of the Werner's syndrome gene.

Authors:  C E Yu; J Oshima; Y H Fu; E M Wijsman; F Hisama; R Alisch; S Matthews; J Nakura; T Miki; S Ouais; G M Martin; J Mulligan; G D Schellenberg
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

6.  Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives.

Authors:  Shiran Yehezkel; Annie Rebibo-Sabbah; Yardena Segev; Maty Tzukerman; Rony Shaked; Irit Huber; Lior Gepstein; Karl Skorecki; Sara Selig
Journal:  Epigenetics       Date:  2011-01-01       Impact factor: 4.528

7.  Clonal chromosomal aberrations accompanied by strong telomerase activity in immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.

Authors:  M Okubo; Y Tsurukubo; T Higaki; T Kawabe; M Goto; T Murase; T Ide; Y Furuichi; M Sugimoto
Journal:  Cancer Genet Cytogenet       Date:  2001-08

Review 8.  Telomere dynamics and telomerase activity in in vitro immortalised human cells.

Authors:  T M Bryan; R R Reddel
Journal:  Eur J Cancer       Date:  1997-04       Impact factor: 9.162

9.  Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway.

Authors:  Purnima R Laud; Asha S Multani; Susan M Bailey; Ling Wu; Jin Ma; Charles Kingsley; Michel Lebel; Sen Pathak; Ronald A DePinho; Sandy Chang
Journal:  Genes Dev       Date:  2005-11-01       Impact factor: 11.361

Review 10.  Senescence and immortalization: role of telomeres and telomerase.

Authors:  Jerry W Shay; Woodring E Wright
Journal:  Carcinogenesis       Date:  2004-10-07       Impact factor: 4.944

View more
  3 in total

1.  Non-enzymatic function of WRN RECQL helicase regulates removal of topoisomerase-I-DNA covalent complexes and triggers NF-κB signaling in cancer.

Authors:  Pooja Gupta; Ananda Guha Majumdar; Birija Sankar Patro
Journal:  Aging Cell       Date:  2022-05-18       Impact factor: 11.005

Review 2.  Recent Advances in Understanding Werner Syndrome.

Authors:  Raghavendra A Shamanna; Deborah L Croteau; Jong-Hyuk Lee; Vilhelm A Bohr
Journal:  F1000Res       Date:  2017-09-28

3.  Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.

Authors:  Raghavendra A Shamanna; Huiming Lu; Deborah L Croteau; Arvind Arora; Devika Agarwal; Graham Ball; Mohammed A Aleskandarany; Ian O Ellis; Yves Pommier; Srinivasan Madhusudan; Vilhelm A Bohr
Journal:  Oncotarget       Date:  2016-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.